|
1
|
TGF-β - an excellent servant but a bad master.
|
J Transl Med
|
2012
|
1.41
|
|
2
|
Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.
|
Haematologica
|
2013
|
1.22
|
|
3
|
Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia.
|
J Exp Med
|
2010
|
1.15
|
|
4
|
Proteasome inhibitors - molecular basis and current perspectives in multiple myeloma.
|
J Cell Mol Med
|
2014
|
0.92
|
|
5
|
Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cells.
|
Int J Colorectal Dis
|
2012
|
0.90
|
|
6
|
Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse.
|
Haematologica
|
2013
|
0.89
|
|
7
|
Serum miR-29a as a marker of multiple myeloma.
|
Leuk Lymphoma
|
2012
|
0.88
|
|
8
|
PML-RARα co-operates with Sox4 in acute myeloid leukemia development in mice.
|
Haematologica
|
2012
|
0.87
|
|
9
|
Mechanism of immunomodulatory drugs in multiple myeloma.
|
Leuk Res
|
2012
|
0.86
|
|
10
|
Dual treatment with FLT3 inhibitor SU11657 and doxorubicin increases survival of leukemic mice.
|
Leuk Res
|
2006
|
0.85
|
|
11
|
Gain(1)(q21) is an unfavorable genetic prognostic factor for patients with relapsed multiple myeloma treated with thalidomide but not for those treated with bortezomib.
|
Clin Lymphoma Myeloma Leuk
|
2013
|
0.82
|
|
12
|
Molecular heterogeneity and centrosome-associated genes in multiple myeloma.
|
Leuk Lymphoma
|
2013
|
0.79
|
|
13
|
Identification of microRNAs regulated by isothiocyanates and association of polymorphisms inside their target sites with risk of sporadic colorectal cancer.
|
Nutr Cancer
|
2013
|
0.79
|
|
14
|
Clinical implication of centrosome amplification and expression of centrosomal functional genes in multiple myeloma.
|
J Transl Med
|
2013
|
0.78
|
|
15
|
Bone marrow plasma cell separation - validation of separation algorithm.
|
Clin Chem Lab Med
|
2012
|
0.78
|
|
16
|
High frequency of temperature-sensitive mutants of p53 in glioblastoma.
|
Pathol Oncol Res
|
2013
|
0.78
|
|
17
|
Combination of serum microRNA-320a and microRNA-320b as a marker for Waldenström macroglobulinemia.
|
Am J Hematol
|
2015
|
0.77
|
|
18
|
Association of aneuploidy category with centrosome amplification in multiple myeloma.
|
Leuk Lymphoma
|
2011
|
0.77
|
|
19
|
Association study of selected genetic polymorphisms and occurrence of venous thromboembolism in patients with multiple myeloma who were treated with thalidomide.
|
Clin Lymphoma Myeloma Leuk
|
2011
|
0.76
|
|
20
|
Cell cycle genes co-expression in multiple myeloma and plasma cell leukemia.
|
Genomics
|
2013
|
0.76
|
|
21
|
Nestin expression throughout multistep pathogenesis of multiple myeloma.
|
Br J Haematol
|
2013
|
0.76
|
|
22
|
Bone marrow plasma cell separation - validation of separation algorithm.
|
Clin Chem Lab Med
|
2012
|
0.75
|